Breaking News

Neuca Clinical Trials Purchases 72.6% Stake in OncoBay

Increases its clinical operations in the U.S. by joining forces with the Florida-based CRO.

Author Image

By: Charlie Sternberg

Associate Editor

Neuca Clinical Trials Inc., a holding company held by Neuca Group, the proprietor of Clinscience international CRO, has increased its clinical operations in the U.S. by purchasing a 72.6% stake in OncoBay, a Tampa, Florida-based CRO founded by Moffit Cancer Center.   OncoBay is a boutique CRO offering comprehensive, custom-curated solutions for biotechnology companies developing avant-garde immuno-oncology therapies. The company provides unrivaled scientific support and conducts clinical opera...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters